TY - JOUR
T1 - Global burden of hepatitis C
T2 - considerations for healthcare providers in the United States.
AU - Averhoff, Francisco M.
AU - Glass, Nancy
AU - Holtzman, Deborah
N1 - Funding Information:
Supplement sponsorship. This article was published as part of a supplement entitled “The Evolving Paradigm of Hepatitis C,” sponsored by an unrestricted grant from the Viral Hepatitis Action Coalition of the CDC Foundation. Potential conflicts of interest. All authors: No reported conflicts.
PY - 2012/7
Y1 - 2012/7
N2 - An estimated 2%-3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including cirrhosis and liver cancer. The epidemiology and burden of HCV infection varies throughout the world, with country-specific prevalence ranging from <1% to >10%. In contrast to the United States and other developed countries, HCV transmission in developing countries frequently results from exposure to infected blood in healthcare and community settings. Hepatitis C prevention, care, and treatment programs must recognize country-specific epidemiology, which varies by setting and level of economic development. Awareness of the global epidemiology of HCV infection is important for US healthcare providers treating foreign-born patients from countries where HCV infection is endemic and for counseling patients who travel to these countries. Countries with a high burden of HCV infection also would benefit from establishing comprehensive prevention, care, and treatment programs.
AB - An estimated 2%-3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including cirrhosis and liver cancer. The epidemiology and burden of HCV infection varies throughout the world, with country-specific prevalence ranging from <1% to >10%. In contrast to the United States and other developed countries, HCV transmission in developing countries frequently results from exposure to infected blood in healthcare and community settings. Hepatitis C prevention, care, and treatment programs must recognize country-specific epidemiology, which varies by setting and level of economic development. Awareness of the global epidemiology of HCV infection is important for US healthcare providers treating foreign-born patients from countries where HCV infection is endemic and for counseling patients who travel to these countries. Countries with a high burden of HCV infection also would benefit from establishing comprehensive prevention, care, and treatment programs.
UR - http://www.scopus.com/inward/record.url?scp=84867308646&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867308646&partnerID=8YFLogxK
U2 - 10.1093/cid/cis361
DO - 10.1093/cid/cis361
M3 - Article
C2 - 22715208
AN - SCOPUS:84867308646
SN - 1058-4838
VL - 55 Suppl 1
SP - S10-15
JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ER -